- Pharmaceutical development of a parenteral lyophilized formulation of the novel indoloquinone antitumor agent EO9. Jonkman-de Vries, J.D., Talsma, H., Henrar, R.E., Kettenes-van den Bosch, J.J., Bult, A., Beijnen, J.H. Cancer Chemother. Pharmacol. (1994)